

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 5.39922174 |
| 2 | neuron cell-cell adhesion (GO:0007158) | 4.93716140 |
| 3 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.86195082 |
| 4 | glutamate secretion (GO:0014047) | 4.75943118 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.66813014 |
| 6 | vocalization behavior (GO:0071625) | 4.43924516 |
| 7 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.37003200 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.30885956 |
| 9 | * ATP hydrolysis coupled proton transport (GO:0015991) | 4.29066276 |
| 10 | * energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 4.29066276 |
| 11 | * transferrin transport (GO:0033572) | 4.27754223 |
| 12 | regulation of synaptic vesicle transport (GO:1902803) | 4.26583420 |
| 13 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.25531172 |
| 14 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.25422212 |
| 15 | presynaptic membrane assembly (GO:0097105) | 4.12837435 |
| 16 | protein localization to synapse (GO:0035418) | 4.09701293 |
| 17 | neuronal action potential propagation (GO:0019227) | 4.08196967 |
| 18 | synaptic vesicle maturation (GO:0016188) | 4.03276005 |
| 19 | * trivalent inorganic cation transport (GO:0072512) | 3.99713268 |
| 20 | * ferric iron transport (GO:0015682) | 3.99713268 |
| 21 | neurotransmitter secretion (GO:0007269) | 3.97962235 |
| 22 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.97783830 |
| 23 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.94737652 |
| 24 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.94168649 |
| 25 | presynaptic membrane organization (GO:0097090) | 3.81047381 |
| 26 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.75837407 |
| 27 | neuron-neuron synaptic transmission (GO:0007270) | 3.71017396 |
| 28 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.67059880 |
| 29 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.65946868 |
| 30 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.64316633 |
| 31 | cellular potassium ion homeostasis (GO:0030007) | 3.62786543 |
| 32 | long-term synaptic potentiation (GO:0060291) | 3.58699418 |
| 33 | neurofilament cytoskeleton organization (GO:0060052) | 3.56516516 |
| 34 | glutamate receptor signaling pathway (GO:0007215) | 3.51385800 |
| 35 | negative regulation of amino acid transport (GO:0051956) | 3.48105983 |
| 36 | synaptic transmission, glutamatergic (GO:0035249) | 3.45739596 |
| 37 | * phagosome maturation (GO:0090382) | 3.44679499 |
| 38 | neuromuscular process controlling posture (GO:0050884) | 3.44295144 |
| 39 | ganglioside metabolic process (GO:0001573) | 3.42016174 |
| 40 | neuron recognition (GO:0008038) | 3.41471927 |
| 41 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.33277984 |
| 42 | neurotransmitter transport (GO:0006836) | 3.33017039 |
| 43 | proline transport (GO:0015824) | 3.32144179 |
| 44 | regulation of vesicle fusion (GO:0031338) | 3.32071552 |
| 45 | acidic amino acid transport (GO:0015800) | 3.31410197 |
| 46 | postsynaptic membrane organization (GO:0001941) | 3.30498740 |
| 47 | glycosphingolipid catabolic process (GO:0046479) | 3.30496412 |
| 48 | gamma-aminobutyric acid transport (GO:0015812) | 3.28417003 |
| 49 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.24571774 |
| 50 | locomotory exploration behavior (GO:0035641) | 3.23899818 |
| 51 | regulation of neurotransmitter secretion (GO:0046928) | 3.18188484 |
| 52 | oligosaccharide catabolic process (GO:0009313) | 3.16757853 |
| 53 | regulation of glutamate secretion (GO:0014048) | 3.15673101 |
| 54 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.10966287 |
| 55 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.10128911 |
| 56 | negative regulation of dendrite development (GO:2000171) | 3.08932722 |
| 57 | startle response (GO:0001964) | 3.08340059 |
| 58 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.07586651 |
| 59 | regulation of neurotransmitter levels (GO:0001505) | 3.07130905 |
| 60 | L-glutamate transport (GO:0015813) | 3.06912801 |
| 61 | synaptic vesicle endocytosis (GO:0048488) | 3.06811596 |
| 62 | establishment of synaptic vesicle localization (GO:0097480) | 3.06312005 |
| 63 | synaptic vesicle transport (GO:0048489) | 3.06312005 |
| 64 | exploration behavior (GO:0035640) | 3.05081548 |
| 65 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.05021062 |
| 66 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.03000649 |
| 67 | regulation of synaptic plasticity (GO:0048167) | 3.02063011 |
| 68 | regulation of mononuclear cell migration (GO:0071675) | 3.01788349 |
| 69 | transmission of nerve impulse (GO:0019226) | 3.01402034 |
| 70 | detection of calcium ion (GO:0005513) | 3.00319661 |
| 71 | regulation of postsynaptic membrane potential (GO:0060078) | 2.99692617 |
| 72 | glycolipid catabolic process (GO:0019377) | 2.98725510 |
| 73 | regulation of neurotransmitter transport (GO:0051588) | 2.97862971 |
| 74 | response to histamine (GO:0034776) | 2.97142810 |
| 75 | establishment of melanosome localization (GO:0032401) | 2.96847317 |
| 76 | regulation of synapse structural plasticity (GO:0051823) | 2.96612314 |
| 77 | negative regulation of neurotransmitter transport (GO:0051589) | 2.96240054 |
| 78 | axonal fasciculation (GO:0007413) | 2.95500877 |
| 79 | positive regulation of membrane potential (GO:0045838) | 2.94760411 |
| 80 | sodium ion export (GO:0071436) | 2.94473747 |
| 81 | establishment of pigment granule localization (GO:0051905) | 2.94296850 |
| 82 | melanosome transport (GO:0032402) | 2.92391530 |
| 83 | positive regulation of neurotransmitter transport (GO:0051590) | 2.92364717 |
| 84 | L-amino acid import (GO:0043092) | 2.92252206 |
| 85 | amino acid import (GO:0043090) | 2.91311513 |
| 86 | establishment of vesicle localization (GO:0051650) | 2.90053476 |
| 87 | pigment granule transport (GO:0051904) | 2.89927668 |
| 88 | synapse assembly (GO:0007416) | 2.89640669 |
| 89 | amino sugar catabolic process (GO:0046348) | 2.85754636 |
| 90 | behavioral response to cocaine (GO:0048148) | 2.84768463 |
| 91 | positive regulation of synapse assembly (GO:0051965) | 2.84496800 |
| 92 | adult walking behavior (GO:0007628) | 2.83356249 |
| 93 | ceramide catabolic process (GO:0046514) | 2.82961954 |
| 94 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.82384828 |
| 95 | synaptic transmission (GO:0007268) | 2.81384136 |
| 96 | vesicle transport along microtubule (GO:0047496) | 2.80637061 |
| 97 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.80614476 |
| 98 | positive regulation of synaptic transmission (GO:0050806) | 2.80500033 |
| 99 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.79943360 |
| 100 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.79422088 |
| 101 | * iron ion transport (GO:0006826) | 2.77279307 |
| 102 | female mating behavior (GO:0060180) | 2.76641906 |
| 103 | calcium ion-dependent exocytosis (GO:0017156) | 2.75583460 |
| 104 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.74696909 |
| 105 | layer formation in cerebral cortex (GO:0021819) | 2.73933670 |
| 106 | * cellular iron ion homeostasis (GO:0006879) | 2.72094696 |
| 107 | cerebellar granule cell differentiation (GO:0021707) | 2.71242825 |
| 108 | protein localization to cilium (GO:0061512) | 2.70994893 |
| 109 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.70063775 |
| 110 | regulation of synaptic transmission (GO:0050804) | 2.69057837 |
| 111 | eosinophil chemotaxis (GO:0048245) | 2.68809342 |
| 112 | dendrite development (GO:0016358) | 2.68689266 |
| 113 | neuronal ion channel clustering (GO:0045161) | 2.68566757 |
| 114 | striatum development (GO:0021756) | 2.68155671 |
| 115 | negative regulation of microtubule polymerization (GO:0031115) | 2.68102069 |
| 116 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.67701107 |
| 117 | regulation of female receptivity (GO:0045924) | 2.67452065 |
| 118 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.65534843 |
| 119 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.65518837 |
| 120 | positive regulation of vesicle fusion (GO:0031340) | 2.65392088 |
| 121 | establishment of mitochondrion localization (GO:0051654) | 2.64080348 |
| 122 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.63337224 |
| 123 | regulation of exocytosis (GO:0017157) | 2.63207045 |
| 124 | mechanosensory behavior (GO:0007638) | 2.62997430 |
| 125 | membrane depolarization (GO:0051899) | 2.62910555 |
| 126 | response to auditory stimulus (GO:0010996) | 2.62356030 |
| 127 | chaperone-mediated protein transport (GO:0072321) | 2.62140677 |
| 128 | long-term memory (GO:0007616) | 2.62132777 |
| 129 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.62068467 |
| 130 | activation of protein kinase A activity (GO:0034199) | 2.61865958 |
| 131 | melanosome localization (GO:0032400) | 2.59881536 |
| 132 | vesicle docking involved in exocytosis (GO:0006904) | 2.59579451 |
| 133 | nucleobase catabolic process (GO:0046113) | 2.59297905 |
| 134 | pigment granule localization (GO:0051875) | 2.59013737 |
| 135 | response to dietary excess (GO:0002021) | 2.58903109 |
| 136 | glycerophospholipid catabolic process (GO:0046475) | 2.57186672 |
| 137 | righting reflex (GO:0060013) | 2.55213555 |
| 138 | protein localization to endosome (GO:0036010) | 2.55203558 |
| 139 | positive regulation of heat generation (GO:0031652) | 2.54149911 |
| 140 | positive regulation of dendritic spine development (GO:0060999) | 2.52025630 |
| 141 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.51907685 |
| 142 | membrane lipid catabolic process (GO:0046466) | 2.50841916 |
| 143 | vesicle docking (GO:0048278) | 2.48648001 |
| 144 | response to acidic pH (GO:0010447) | 2.48448605 |
| 145 | neuromuscular process controlling balance (GO:0050885) | 2.46828259 |
| 146 | regulation of fever generation (GO:0031620) | 2.43774343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.80960971 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.64438511 |
| 3 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.05869903 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.92091921 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.69127308 |
| 6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.57141632 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.50090101 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.49377026 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.43212943 |
| 10 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.40869760 |
| 11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.36408264 |
| 12 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.36402791 |
| 13 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.30650136 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.27322345 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.25445066 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.21071476 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.17697887 |
| 18 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.15118266 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.14433476 |
| 20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.14048547 |
| 21 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.13683842 |
| 22 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.12508463 |
| 23 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.12508463 |
| 24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.11487651 |
| 25 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.11200774 |
| 26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.09877072 |
| 27 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.07044282 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.05538585 |
| 29 | P300_19829295_ChIP-Seq_ESCs_Human | 2.02698505 |
| 30 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.97564568 |
| 31 | VDR_22108803_ChIP-Seq_LS180_Human | 1.96039173 |
| 32 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.91100166 |
| 33 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.86891931 |
| 34 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.81354210 |
| 35 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.77504119 |
| 36 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.77463666 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.75859159 |
| 38 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.73450312 |
| 39 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.73432995 |
| 40 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.73045081 |
| 41 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.72945125 |
| 42 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.71093616 |
| 43 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.68604032 |
| 44 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.67061758 |
| 45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.62784261 |
| 46 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.61770150 |
| 47 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.61008551 |
| 48 | FUS_26573619_Chip-Seq_HEK293_Human | 1.60114319 |
| 49 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.57976695 |
| 50 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.57333082 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.55703318 |
| 52 | AR_25329375_ChIP-Seq_VCAP_Human | 1.54140259 |
| 53 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.53391755 |
| 54 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.51928571 |
| 55 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.45324217 |
| 56 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.40164628 |
| 57 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.37338300 |
| 58 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.36830345 |
| 59 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36528961 |
| 60 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.33332935 |
| 61 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.33230006 |
| 62 | JUN_21703547_ChIP-Seq_K562_Human | 1.31886362 |
| 63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.31119753 |
| 64 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.28876773 |
| 65 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.28709791 |
| 66 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.26150560 |
| 67 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.24896657 |
| 68 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.24047057 |
| 69 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.23511243 |
| 70 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.23069857 |
| 71 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.21676834 |
| 72 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.20578739 |
| 73 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.20292418 |
| 74 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.19889281 |
| 75 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.19039133 |
| 76 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.18714209 |
| 77 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.18227345 |
| 78 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.17983694 |
| 79 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.17434648 |
| 80 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.17285362 |
| 81 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.14252407 |
| 82 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.14252407 |
| 83 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.13397243 |
| 84 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.13305108 |
| 85 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.12072970 |
| 86 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.11433683 |
| 87 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10512610 |
| 88 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.08924080 |
| 89 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.08699178 |
| 90 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.08176864 |
| 91 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.07896701 |
| 92 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.07419086 |
| 93 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.07040474 |
| 94 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.06520105 |
| 95 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.06120391 |
| 96 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.05917322 |
| 97 | KDM2B_26808549_Chip-Seq_REH_Human | 1.05515210 |
| 98 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05126026 |
| 99 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04897722 |
| 100 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.04597525 |
| 101 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.03833910 |
| 102 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03139051 |
| 103 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02984242 |
| 104 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.02565577 |
| 105 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.02386653 |
| 106 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.00956656 |
| 107 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.00457327 |
| 108 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 1.00119995 |
| 109 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.99668282 |
| 110 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99431825 |
| 111 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.99409431 |
| 112 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.99409431 |
| 113 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.98938573 |
| 114 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98740105 |
| 115 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98729254 |
| 116 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.97845600 |
| 117 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.97833907 |
| 118 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96740143 |
| 119 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.96317441 |
| 120 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.96229401 |
| 121 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.94848745 |
| 122 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94275459 |
| 123 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.94260918 |
| 124 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94124542 |
| 125 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.94062110 |
| 126 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.93670018 |
| 127 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.93598960 |
| 128 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.92653660 |
| 129 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.92336127 |
| 130 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.91574171 |
| 131 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.91368469 |
| 132 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88173794 |
| 133 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.86956560 |
| 134 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.86305124 |
| 135 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.86162085 |
| 136 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.85911967 |
| 137 | * P300_18555785_Chip-Seq_ESCs_Mouse | 0.84686198 |
| 138 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84441079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.08730502 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.77578036 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.63291240 |
| 4 | MP0004270_analgesia | 3.43811316 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.27548454 |
| 6 | MP0009745_abnormal_behavioral_response | 3.25665675 |
| 7 | MP0001968_abnormal_touch/_nociception | 3.20061014 |
| 8 | MP0002064_seizures | 3.16928109 |
| 9 | MP0009046_muscle_twitch | 3.10497595 |
| 10 | MP0002063_abnormal_learning/memory/cond | 3.04252345 |
| 11 | MP0002736_abnormal_nociception_after | 2.92552126 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.81343438 |
| 13 | MP0002735_abnormal_chemical_nociception | 2.75386344 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.69570464 |
| 15 | MP0006276_abnormal_autonomic_nervous | 2.65131095 |
| 16 | MP0002272_abnormal_nervous_system | 2.57518617 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.46791129 |
| 18 | MP0002822_catalepsy | 2.35572906 |
| 19 | MP0009840_abnormal_foam_cell | 2.35454044 |
| 20 | MP0001440_abnormal_grooming_behavior | 2.28686969 |
| 21 | MP0001529_abnormal_vocalization | 2.25336548 |
| 22 | MP0001486_abnormal_startle_reflex | 2.23016551 |
| 23 | MP0002733_abnormal_thermal_nociception | 2.17511518 |
| 24 | MP0001970_abnormal_pain_threshold | 2.11540089 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 2.06838386 |
| 26 | MP0002067_abnormal_sensory_capabilities | 2.03320072 |
| 27 | MP0010386_abnormal_urinary_bladder | 1.99509742 |
| 28 | MP0005167_abnormal_blood-brain_barrier | 1.98276903 |
| 29 | MP0005646_abnormal_pituitary_gland | 1.93820851 |
| 30 | MP0001984_abnormal_olfaction | 1.90454513 |
| 31 | MP0001905_abnormal_dopamine_level | 1.81438119 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.80322618 |
| 33 | MP0004924_abnormal_behavior | 1.78911449 |
| 34 | MP0005386_behavior/neurological_phenoty | 1.78911449 |
| 35 | MP0002876_abnormal_thyroid_physiology | 1.78736951 |
| 36 | MP0000343_altered_response_to | 1.77554539 |
| 37 | MP0000778_abnormal_nervous_system | 1.76402128 |
| 38 | MP0002184_abnormal_innervation | 1.76109586 |
| 39 | MP0001188_hyperpigmentation | 1.74445277 |
| 40 | MP0003329_amyloid_beta_deposits | 1.74438726 |
| 41 | MP0004858_abnormal_nervous_system | 1.70195052 |
| 42 | MP0005645_abnormal_hypothalamus_physiol | 1.66069468 |
| 43 | MP0005423_abnormal_somatic_nervous | 1.62948892 |
| 44 | MP0003303_peritoneal_inflammation | 1.62356320 |
| 45 | MP0006082_CNS_inflammation | 1.60944897 |
| 46 | MP0003879_abnormal_hair_cell | 1.59764656 |
| 47 | MP0002557_abnormal_social/conspecific_i | 1.59630969 |
| 48 | MP0002909_abnormal_adrenal_gland | 1.59517035 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.55522008 |
| 50 | MP0004811_abnormal_neuron_physiology | 1.54750995 |
| 51 | MP0003075_altered_response_to | 1.52975372 |
| 52 | MP0003787_abnormal_imprinting | 1.47931045 |
| 53 | MP0004510_myositis | 1.46475923 |
| 54 | MP0004142_abnormal_muscle_tone | 1.44859908 |
| 55 | MP0005171_absent_coat_pigmentation | 1.43130757 |
| 56 | MP0003806_abnormal_nucleotide_metabolis | 1.38748595 |
| 57 | MP0002837_dystrophic_cardiac_calcinosis | 1.35000567 |
| 58 | MP0000955_abnormal_spinal_cord | 1.34138563 |
| 59 | MP0003122_maternal_imprinting | 1.33821357 |
| 60 | MP0002066_abnormal_motor_capabilities/c | 1.33038782 |
| 61 | MP0000013_abnormal_adipose_tissue | 1.28723746 |
| 62 | MP0008569_lethality_at_weaning | 1.28406361 |
| 63 | MP0002148_abnormal_hypersensitivity_rea | 1.28127067 |
| 64 | MP0002882_abnormal_neuron_morphology | 1.27681340 |
| 65 | MP0002139_abnormal_hepatobiliary_system | 1.21733277 |
| 66 | MP0003633_abnormal_nervous_system | 1.18643644 |
| 67 | MP0001502_abnormal_circadian_rhythm | 1.17790588 |
| 68 | MP0001986_abnormal_taste_sensitivity | 1.17054281 |
| 69 | MP0004043_abnormal_pH_regulation | 1.13182806 |
| 70 | MP0002102_abnormal_ear_morphology | 1.10896217 |
| 71 | MP0000604_amyloidosis | 1.09121528 |
| 72 | MP0003631_nervous_system_phenotype | 1.07552653 |
| 73 | MP0009764_decreased_sensitivity_to | 1.06892608 |
| 74 | MP0004742_abnormal_vestibular_system | 1.05577518 |
| 75 | MP0005535_abnormal_body_temperature | 1.04808185 |
| 76 | MP0002332_abnormal_exercise_endurance | 1.02931579 |
| 77 | MP0002229_neurodegeneration | 1.01921955 |
| 78 | MP0009785_altered_susceptibility_to | 1.00738000 |
| 79 | MP0004885_abnormal_endolymph | 1.00348782 |
| 80 | MP0002638_abnormal_pupillary_reflex | 0.99005448 |
| 81 | MP0002069_abnormal_eating/drinking_beha | 0.96283824 |
| 82 | MP0005253_abnormal_eye_physiology | 0.93906174 |
| 83 | MP0005551_abnormal_eye_electrophysiolog | 0.92900762 |
| 84 | MP0008872_abnormal_physiological_respon | 0.92252723 |
| 85 | MP0004147_increased_porphyrin_level | 0.92197929 |
| 86 | MP0003634_abnormal_glial_cell | 0.91763505 |
| 87 | MP0003195_calcinosis | 0.91652354 |
| 88 | MP0001963_abnormal_hearing_physiology | 0.91536055 |
| 89 | MP0003186_abnormal_redox_activity | 0.90195620 |
| 90 | MP0005499_abnormal_olfactory_system | 0.87752405 |
| 91 | MP0005394_taste/olfaction_phenotype | 0.87752405 |
| 92 | MP0001664_abnormal_digestion | 0.86663148 |
| 93 | MP0003123_paternal_imprinting | 0.86464772 |
| 94 | MP0003300_gastrointestinal_ulcer | 0.85273590 |
| 95 | MP0002152_abnormal_brain_morphology | 0.84661171 |
| 96 | MP0002090_abnormal_vision | 0.84378210 |
| 97 | MP0000372_irregular_coat_pigmentation | 0.84356952 |
| 98 | MP0001177_atelectasis | 0.82988648 |
| 99 | MP0003172_abnormal_lysosome_physiology | 0.80777765 |
| 100 | MP0003632_abnormal_nervous_system | 0.80710297 |
| 101 | MP0008260_abnormal_autophagy | 0.80227048 |
| 102 | MP0000920_abnormal_myelination | 0.77940852 |
| 103 | MP0000371_diluted_coat_color | 0.75667590 |
| 104 | MP0005379_endocrine/exocrine_gland_phen | 0.75328593 |
| 105 | MP0001542_abnormal_bone_strength | 0.74702115 |
| 106 | MP0003656_abnormal_erythrocyte_physiolo | 0.73174102 |
| 107 | MP0000681_abnormal_thyroid_gland | 0.72115652 |
| 108 | MP0000631_abnormal_neuroendocrine_gland | 0.70842408 |
| 109 | MP0000538_abnormal_urinary_bladder | 0.69368919 |
| 110 | MP0002751_abnormal_autonomic_nervous | 0.68440946 |
| 111 | MP0003137_abnormal_impulse_conducting | 0.68411319 |
| 112 | MP0003121_genomic_imprinting | 0.67910227 |
| 113 | MP0002752_abnormal_somatic_nervous | 0.67362386 |
| 114 | MP0005248_abnormal_Harderian_gland | 0.67102614 |
| 115 | MP0008874_decreased_physiological_sensi | 0.66435163 |
| 116 | MP0003690_abnormal_glial_cell | 0.66223741 |
| 117 | MP0006072_abnormal_retinal_apoptosis | 0.65901637 |
| 118 | MP0000015_abnormal_ear_pigmentation | 0.64065391 |
| 119 | MP0005310_abnormal_salivary_gland | 0.63198622 |
| 120 | MP0000569_abnormal_digit_pigmentation | 0.61465420 |
| 121 | MP0004085_abnormal_heartbeat | 0.60900740 |
| 122 | MP0004484_altered_response_of | 0.56955860 |
| 123 | MP0006035_abnormal_mitochondrial_morpho | 0.56022310 |
| 124 | MP0008004_abnormal_stomach_pH | 0.53620242 |
| 125 | MP0005409_darkened_coat_color | 0.51853678 |
| 126 | MP0009697_abnormal_copulation | 0.50832915 |
| 127 | MP0002163_abnormal_gland_morphology | 0.50657483 |
| 128 | MP0001485_abnormal_pinna_reflex | 0.50143600 |
| 129 | MP0000026_abnormal_inner_ear | 0.49610576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.78232611 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 6.18017045 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.18017045 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.18017045 |
| 5 | Atonic seizures (HP:0010819) | 5.49623003 |
| 6 | Epileptic encephalopathy (HP:0200134) | 4.72075849 |
| 7 | Focal seizures (HP:0007359) | 4.64065091 |
| 8 | Myokymia (HP:0002411) | 4.59713706 |
| 9 | Febrile seizures (HP:0002373) | 4.44822766 |
| 10 | Hyperventilation (HP:0002883) | 4.23958572 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 4.23254941 |
| 12 | Absence seizures (HP:0002121) | 4.16955313 |
| 13 | Visual hallucinations (HP:0002367) | 4.16859874 |
| 14 | Pheochromocytoma (HP:0002666) | 4.04805641 |
| 15 | Dialeptic seizures (HP:0011146) | 3.86561705 |
| 16 | Neuroendocrine neoplasm (HP:0100634) | 3.85837757 |
| 17 | Disinhibition (HP:0000734) | 3.83309992 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 3.73391050 |
| 19 | Generalized tonic-clonic seizures (HP:0002069) | 3.59691716 |
| 20 | Apathy (HP:0000741) | 3.56562180 |
| 21 | Diminished motivation (HP:0000745) | 3.52345937 |
| 22 | Progressive cerebellar ataxia (HP:0002073) | 3.49923821 |
| 23 | Hypothermia (HP:0002045) | 3.47287966 |
| 24 | Neuronal loss in central nervous system (HP:0002529) | 3.41426592 |
| 25 | Dysostosis multiplex (HP:0000943) | 3.21240250 |
| 26 | Loss of speech (HP:0002371) | 3.20818865 |
| 27 | Abnormal hair whorl (HP:0010721) | 3.19949109 |
| 28 | Acute necrotizing encephalopathy (HP:0006965) | 3.17356352 |
| 29 | Polyphagia (HP:0002591) | 3.13584961 |
| 30 | Gait imbalance (HP:0002141) | 3.12036815 |
| 31 | Intention tremor (HP:0002080) | 3.06137879 |
| 32 | Abnormal eating behavior (HP:0100738) | 3.00009550 |
| 33 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.96305282 |
| 34 | Limb dystonia (HP:0002451) | 2.96051483 |
| 35 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.94817290 |
| 36 | Amblyopia (HP:0000646) | 2.94429430 |
| 37 | Progressive macrocephaly (HP:0004481) | 2.90042826 |
| 38 | Epileptiform EEG discharges (HP:0011182) | 2.88386214 |
| 39 | Inappropriate behavior (HP:0000719) | 2.86926196 |
| 40 | Medial flaring of the eyebrow (HP:0010747) | 2.86586950 |
| 41 | Supranuclear gaze palsy (HP:0000605) | 2.84551977 |
| 42 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.77843426 |
| 43 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.77843426 |
| 44 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.77843426 |
| 45 | Congenital primary aphakia (HP:0007707) | 2.77767465 |
| 46 | Progressive inability to walk (HP:0002505) | 2.71417346 |
| 47 | Failure to thrive in infancy (HP:0001531) | 2.70519056 |
| 48 | Nephrogenic diabetes insipidus (HP:0009806) | 2.70458872 |
| 49 | EEG with generalized epileptiform discharges (HP:0011198) | 2.68208791 |
| 50 | Broad-based gait (HP:0002136) | 2.62887365 |
| 51 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.62520036 |
| 52 | Mucopolysacchariduria (HP:0008155) | 2.62520036 |
| 53 | Truncal ataxia (HP:0002078) | 2.53500604 |
| 54 | Axonal loss (HP:0003447) | 2.53261021 |
| 55 | Agnosia (HP:0010524) | 2.52578330 |
| 56 | Hypsarrhythmia (HP:0002521) | 2.51076152 |
| 57 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.50011755 |
| 58 | Anxiety (HP:0000739) | 2.49792806 |
| 59 | Mitochondrial inheritance (HP:0001427) | 2.49195344 |
| 60 | Inability to walk (HP:0002540) | 2.48681600 |
| 61 | Excessive salivation (HP:0003781) | 2.44595143 |
| 62 | Drooling (HP:0002307) | 2.44595143 |
| 63 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.42687269 |
| 64 | Cerebral hypomyelination (HP:0006808) | 2.42622860 |
| 65 | Acute encephalopathy (HP:0006846) | 2.39940164 |
| 66 | Ankle clonus (HP:0011448) | 2.38916487 |
| 67 | Poor suck (HP:0002033) | 2.36775481 |
| 68 | Gaze-evoked nystagmus (HP:0000640) | 2.32493222 |
| 69 | Akinesia (HP:0002304) | 2.32289400 |
| 70 | Blue irides (HP:0000635) | 2.30041625 |
| 71 | Action tremor (HP:0002345) | 2.28367222 |
| 72 | Dementia (HP:0000726) | 2.28142393 |
| 73 | Poor eye contact (HP:0000817) | 2.27465652 |
| 74 | Scanning speech (HP:0002168) | 2.26438247 |
| 75 | Neurofibrillary tangles (HP:0002185) | 2.26155435 |
| 76 | Progressive neurologic deterioration (HP:0002344) | 2.26020285 |
| 77 | Abnormality of the motor neurons (HP:0002450) | 2.24511550 |
| 78 | Abnormal neuron morphology (HP:0012757) | 2.24511550 |
| 79 | Absent speech (HP:0001344) | 2.23838615 |
| 80 | Cerebral inclusion bodies (HP:0100314) | 2.23070205 |
| 81 | Nuclear cataract (HP:0100018) | 2.22334901 |
| 82 | Spastic tetraparesis (HP:0001285) | 2.22325743 |
| 83 | Oligomenorrhea (HP:0000876) | 2.21823229 |
| 84 | Genital tract atresia (HP:0001827) | 2.18680427 |
| 85 | Increased serum pyruvate (HP:0003542) | 2.16285117 |
| 86 | Abnormality of glycolysis (HP:0004366) | 2.16285117 |
| 87 | Diplopia (HP:0000651) | 2.16156257 |
| 88 | Abnormality of binocular vision (HP:0011514) | 2.16156257 |
| 89 | Specific learning disability (HP:0001328) | 2.15985127 |
| 90 | Dysmetria (HP:0001310) | 2.15585484 |
| 91 | Depression (HP:0000716) | 2.15352534 |
| 92 | Vaginal atresia (HP:0000148) | 2.15199533 |
| 93 | Increased CSF lactate (HP:0002490) | 2.14882630 |
| 94 | Fetal akinesia sequence (HP:0001989) | 2.13666491 |
| 95 | 3-Methylglutaconic aciduria (HP:0003535) | 2.13221859 |
| 96 | Abnormality of the corticospinal tract (HP:0002492) | 2.12585608 |
| 97 | Dysdiadochokinesis (HP:0002075) | 2.12289683 |
| 98 | Esotropia (HP:0000565) | 2.11431885 |
| 99 | CNS hypomyelination (HP:0003429) | 2.10419713 |
| 100 | Sensorimotor neuropathy (HP:0007141) | 2.09247951 |
| 101 | Protruding tongue (HP:0010808) | 2.08996439 |
| 102 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.05295437 |
| 103 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.05295437 |
| 104 | Spastic gait (HP:0002064) | 2.04763594 |
| 105 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.04470124 |
| 106 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.04446860 |
| 107 | Termporal pattern (HP:0011008) | 2.03851285 |
| 108 | Insidious onset (HP:0003587) | 2.03851285 |
| 109 | Craniofacial dystonia (HP:0012179) | 2.03203796 |
| 110 | Impaired social interactions (HP:0000735) | 2.02775717 |
| 111 | Abnormal social behavior (HP:0012433) | 2.02775717 |
| 112 | Urinary urgency (HP:0000012) | 2.01565567 |
| 113 | Poor coordination (HP:0002370) | 2.01475662 |
| 114 | Delusions (HP:0000746) | 2.01226500 |
| 115 | Tetraplegia (HP:0002445) | 1.99632601 |
| 116 | Hand muscle atrophy (HP:0009130) | 1.98229950 |
| 117 | Generalized myoclonic seizures (HP:0002123) | 1.97992235 |
| 118 | Agitation (HP:0000713) | 1.95682135 |
| 119 | Mutism (HP:0002300) | 1.95528173 |
| 120 | Retinal atrophy (HP:0001105) | 1.94973445 |
| 121 | Peripheral hypomyelination (HP:0007182) | 1.94444524 |
| 122 | Status epilepticus (HP:0002133) | 1.94152822 |
| 123 | Resting tremor (HP:0002322) | 1.93623554 |
| 124 | Hyperthyroidism (HP:0000836) | 1.93387853 |
| 125 | Personality changes (HP:0000751) | 1.92345133 |
| 126 | Bradykinesia (HP:0002067) | 1.92072620 |
| 127 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.90821266 |
| 128 | Autoamputation (HP:0001218) | 1.89497346 |
| 129 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.89188915 |
| 130 | Abnormality of the anterior horn cell (HP:0006802) | 1.87827047 |
| 131 | Degeneration of anterior horn cells (HP:0002398) | 1.87827047 |
| 132 | Postural instability (HP:0002172) | 1.86989723 |
| 133 | Generalized aminoaciduria (HP:0002909) | 1.85651287 |
| 134 | Global brain atrophy (HP:0002283) | 1.85428861 |
| 135 | Psychosis (HP:0000709) | 1.84206736 |
| 136 | Spastic tetraplegia (HP:0002510) | 1.82845221 |
| 137 | Lower limb muscle weakness (HP:0007340) | 1.82583097 |
| 138 | Hypokinesia (HP:0002375) | 1.82552224 |
| 139 | Amyotrophic lateral sclerosis (HP:0007354) | 1.82347493 |
| 140 | Hepatocellular necrosis (HP:0001404) | 1.81789059 |
| 141 | Hypoventilation (HP:0002791) | 1.81304198 |
| 142 | Postural tremor (HP:0002174) | 1.79672053 |
| 143 | Abnormality of salivation (HP:0100755) | 1.79575777 |
| 144 | Myoclonus (HP:0001336) | 1.79164165 |
| 145 | Frequent falls (HP:0002359) | 1.78425026 |
| 146 | Focal dystonia (HP:0004373) | 1.77748144 |
| 147 | Muscular hypotonia of the trunk (HP:0008936) | 1.77648640 |
| 148 | Torticollis (HP:0000473) | 1.77441114 |
| 149 | Optic disc pallor (HP:0000543) | 1.76811738 |
| 150 | Lissencephaly (HP:0001339) | 1.76028045 |
| 151 | Gait ataxia (HP:0002066) | 1.75302518 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.37650647 |
| 2 | MAP3K12 | 3.71359447 |
| 3 | NTRK3 | 3.69518038 |
| 4 | MAP2K7 | 3.21809323 |
| 5 | EPHA4 | 3.11336628 |
| 6 | MAP3K4 | 2.92631669 |
| 7 | MAP3K9 | 2.66929990 |
| 8 | MARK1 | 2.59298300 |
| 9 | MINK1 | 2.37017782 |
| 10 | PLK2 | 2.35076108 |
| 11 | TESK1 | 2.20975692 |
| 12 | RIPK4 | 2.20535231 |
| 13 | ARAF | 2.01867924 |
| 14 | DAPK2 | 1.93820988 |
| 15 | PIM2 | 1.91100849 |
| 16 | NME2 | 1.89185697 |
| 17 | BMPR2 | 1.78155129 |
| 18 | CDK19 | 1.77724831 |
| 19 | DAPK1 | 1.76715653 |
| 20 | PINK1 | 1.76256007 |
| 21 | MAP2K4 | 1.74008236 |
| 22 | OXSR1 | 1.73133016 |
| 23 | TRIM28 | 1.71944488 |
| 24 | AKT3 | 1.67541822 |
| 25 | MAP4K2 | 1.61678391 |
| 26 | GRK5 | 1.59567785 |
| 27 | PRPF4B | 1.58140199 |
| 28 | NTRK1 | 1.52225944 |
| 29 | MAPK13 | 1.45254375 |
| 30 | MAP3K11 | 1.43056642 |
| 31 | LATS2 | 1.40379652 |
| 32 | TAOK1 | 1.39810600 |
| 33 | IRAK3 | 1.39025810 |
| 34 | BCR | 1.38602527 |
| 35 | NTRK2 | 1.37332304 |
| 36 | SIK3 | 1.29756297 |
| 37 | TNIK | 1.28826324 |
| 38 | CDK5 | 1.28409479 |
| 39 | PRKCG | 1.24400001 |
| 40 | KSR1 | 1.21414797 |
| 41 | SGK223 | 1.20835776 |
| 42 | SGK494 | 1.20835776 |
| 43 | ABL2 | 1.19387669 |
| 44 | ERBB3 | 1.19042552 |
| 45 | PAK6 | 1.15902882 |
| 46 | DDR2 | 1.15377874 |
| 47 | CCNB1 | 1.14726160 |
| 48 | KSR2 | 1.14697569 |
| 49 | CSNK1A1L | 1.13730966 |
| 50 | TSSK6 | 1.10280607 |
| 51 | PNCK | 1.09221637 |
| 52 | CAMK2A | 1.06369314 |
| 53 | BRAF | 1.03407652 |
| 54 | MAP3K5 | 1.00878213 |
| 55 | SGK2 | 1.00673088 |
| 56 | CAMK2B | 1.00616765 |
| 57 | CAMKK2 | 0.99140534 |
| 58 | PDK3 | 0.98118379 |
| 59 | PDK4 | 0.98118379 |
| 60 | GRK7 | 0.97356298 |
| 61 | PRKCE | 0.97077191 |
| 62 | NME1 | 0.96819388 |
| 63 | BMPR1B | 0.91543490 |
| 64 | MAP3K2 | 0.89873233 |
| 65 | TAOK2 | 0.88544837 |
| 66 | WNK3 | 0.87063327 |
| 67 | CAMK1D | 0.86570096 |
| 68 | CSNK1G2 | 0.83317560 |
| 69 | CDK14 | 0.82299779 |
| 70 | FRK | 0.81898263 |
| 71 | UHMK1 | 0.81077786 |
| 72 | CDK18 | 0.80726802 |
| 73 | SCYL2 | 0.79489931 |
| 74 | LIMK1 | 0.79333197 |
| 75 | DYRK3 | 0.77670666 |
| 76 | MOS | 0.76728794 |
| 77 | CSNK1G1 | 0.75931513 |
| 78 | FES | 0.75225211 |
| 79 | FGR | 0.74746440 |
| 80 | CAMK1 | 0.73843609 |
| 81 | CDK15 | 0.71761330 |
| 82 | PTK2B | 0.71524191 |
| 83 | NEK1 | 0.69948172 |
| 84 | MAP3K13 | 0.68321922 |
| 85 | ADRBK2 | 0.68213741 |
| 86 | SIK2 | 0.67531065 |
| 87 | PDK2 | 0.66830527 |
| 88 | PAK3 | 0.65980438 |
| 89 | ACVR1B | 0.64804946 |
| 90 | CAMKK1 | 0.64625659 |
| 91 | CAMK2D | 0.63117862 |
| 92 | MAP2K1 | 0.62290749 |
| 93 | DYRK1A | 0.61233058 |
| 94 | ERBB4 | 0.59383810 |
| 95 | CDK11A | 0.58718932 |
| 96 | MATK | 0.56798606 |
| 97 | TESK2 | 0.55693323 |
| 98 | ADRBK1 | 0.55515807 |
| 99 | DYRK2 | 0.54135513 |
| 100 | STK39 | 0.53167352 |
| 101 | SGK1 | 0.52858140 |
| 102 | PRKCH | 0.52658162 |
| 103 | CSNK1G3 | 0.52522434 |
| 104 | FER | 0.51877624 |
| 105 | PKN1 | 0.50878058 |
| 106 | CAMK2G | 0.50310253 |
| 107 | SGK3 | 0.49546715 |
| 108 | CAMK4 | 0.48203947 |
| 109 | MAP3K14 | 0.47268653 |
| 110 | INSRR | 0.46149182 |
| 111 | EIF2AK3 | 0.46048026 |
| 112 | ALK | 0.45506505 |
| 113 | RAF1 | 0.44622956 |
| 114 | CAMK1G | 0.43398115 |
| 115 | MST4 | 0.42318208 |
| 116 | PRKD3 | 0.42273952 |
| 117 | MYLK | 0.42007602 |
| 118 | IRAK2 | 0.41662899 |
| 119 | WNK4 | 0.41474518 |
| 120 | DYRK1B | 0.41457170 |
| 121 | CSNK1A1 | 0.41428365 |
| 122 | PRKCZ | 0.40317934 |
| 123 | BCKDK | 0.39679737 |
| 124 | PDPK1 | 0.37247764 |
| 125 | MAP3K1 | 0.37188822 |
| 126 | LMTK2 | 0.36878944 |
| 127 | PHKG2 | 0.36560012 |
| 128 | PHKG1 | 0.36560012 |
| 129 | TGFBR2 | 0.36124598 |
| 130 | ROCK2 | 0.35200424 |
| 131 | RPS6KA2 | 0.34754028 |
| 132 | PRKACA | 0.34744185 |
| 133 | YES1 | 0.34037971 |
| 134 | NEK6 | 0.33258576 |
| 135 | DAPK3 | 0.32856766 |
| 136 | PRKCA | 0.32634303 |
| 137 | PLK3 | 0.32456771 |
| 138 | FYN | 0.32309252 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.25375856 |
| 2 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 4.02595566 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 3.76298987 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.62759027 |
| 5 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.58143086 |
| 6 | * Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.55796834 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.52932522 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.33917396 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.27438781 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 2.21289264 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.20493126 |
| 12 | Long-term potentiation_Homo sapiens_hsa04720 | 2.14469418 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.10506107 |
| 14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.09059121 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 2.05771204 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.00357628 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.88043423 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.84764706 |
| 19 | Parkinsons disease_Homo sapiens_hsa05012 | 1.75697590 |
| 20 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.73494907 |
| 21 | Insulin secretion_Homo sapiens_hsa04911 | 1.73195153 |
| 22 | Alzheimers disease_Homo sapiens_hsa05010 | 1.66126599 |
| 23 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.66108544 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.59634355 |
| 25 | Salivary secretion_Homo sapiens_hsa04970 | 1.57470627 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.55220940 |
| 27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.54809770 |
| 28 | Long-term depression_Homo sapiens_hsa04730 | 1.54422790 |
| 29 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.54179102 |
| 30 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.52699438 |
| 31 | Renin secretion_Homo sapiens_hsa04924 | 1.50705356 |
| 32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.48672227 |
| 33 | Salmonella infection_Homo sapiens_hsa05132 | 1.39582302 |
| 34 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.37058677 |
| 35 | * Phagosome_Homo sapiens_hsa04145 | 1.33323171 |
| 36 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.27002929 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.25931311 |
| 38 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.17540546 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.17499729 |
| 40 | Huntingtons disease_Homo sapiens_hsa05016 | 1.13041815 |
| 41 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.11744871 |
| 42 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.10608290 |
| 43 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.09939823 |
| 44 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.09356245 |
| 45 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.09043535 |
| 46 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.06010877 |
| 47 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.01187770 |
| 48 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.00296733 |
| 49 | Phototransduction_Homo sapiens_hsa04744 | 0.98922630 |
| 50 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.96847856 |
| 51 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.95853685 |
| 52 | Gap junction_Homo sapiens_hsa04540 | 0.93486046 |
| 53 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93422133 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 0.92756183 |
| 55 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.91152372 |
| 56 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.89166811 |
| 57 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.86407176 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 0.86168962 |
| 59 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.83555889 |
| 60 | Axon guidance_Homo sapiens_hsa04360 | 0.80889759 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80211733 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.78189033 |
| 63 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.77327655 |
| 64 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.75721378 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75352723 |
| 66 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.74387260 |
| 67 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.73078988 |
| 68 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.71648481 |
| 69 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68919716 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66774937 |
| 71 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.66453868 |
| 72 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.66358812 |
| 73 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.64287946 |
| 74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.63815045 |
| 75 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.63429727 |
| 76 | * Lysosome_Homo sapiens_hsa04142 | 0.62201223 |
| 77 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.59172485 |
| 78 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57825348 |
| 79 | Shigellosis_Homo sapiens_hsa05131 | 0.56819664 |
| 80 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.56079046 |
| 81 | Glioma_Homo sapiens_hsa05214 | 0.55583374 |
| 82 | Proteasome_Homo sapiens_hsa03050 | 0.54728073 |
| 83 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.53408590 |
| 84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.51907308 |
| 85 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.51677275 |
| 86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48280443 |
| 87 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.47226921 |
| 88 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.46779403 |
| 89 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.46649299 |
| 90 | Melanogenesis_Homo sapiens_hsa04916 | 0.45634149 |
| 91 | Protein export_Homo sapiens_hsa03060 | 0.45464996 |
| 92 | Alcoholism_Homo sapiens_hsa05034 | 0.45269868 |
| 93 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.43382659 |
| 94 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.42223971 |
| 95 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.42080042 |
| 96 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.41194610 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39398126 |
| 98 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39356765 |
| 99 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.39172265 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38739882 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38569561 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38361286 |
| 103 | Prion diseases_Homo sapiens_hsa05020 | 0.37720763 |
| 104 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.37034106 |
| 105 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35014290 |
| 106 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.34975457 |
| 107 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.34072937 |
| 108 | Endocytosis_Homo sapiens_hsa04144 | 0.30921059 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30764492 |
| 110 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.28176174 |
| 111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28082813 |
| 112 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.28063526 |
| 113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.27803934 |
| 114 | Carbon metabolism_Homo sapiens_hsa01200 | 0.27782025 |
| 115 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26560843 |
| 116 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.25855647 |
| 117 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.24835666 |
| 118 | Peroxisome_Homo sapiens_hsa04146 | 0.24742767 |
| 119 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.24417699 |
| 120 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.23501114 |
| 121 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.22453980 |
| 122 | * Tuberculosis_Homo sapiens_hsa05152 | 0.21932898 |
| 123 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21718854 |
| 124 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.20390539 |
| 125 | Circadian rhythm_Homo sapiens_hsa04710 | 0.19713699 |
| 126 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.19409354 |
| 127 | Mineral absorption_Homo sapiens_hsa04978 | 0.18017753 |

